PUS1 is a novel biomarker for evaluating malignancy of human renal cell carcinoma

Renal cell carcinoma (RCC) is one of the most common malignancies. Despite the rapid development of the oncology research and surgical treatment, the prognosis of RCC has not significantly improved. Thus, exploration of the pathological molecular mechanism and development of new therapeutic targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Zhu, Chongying, Xu, Shouying, Xu, Qiang, Xu, Da, Gan, Sishun, Cui, Xingang, Tang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292901/
https://www.ncbi.nlm.nih.gov/pubmed/37315299
http://dx.doi.org/10.18632/aging.204799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292901/
https://www.ncbi.nlm.nih.gov/pubmed/37315299
http://dx.doi.org/10.18632/aging.204799

Ejemplares similares